Pharmaceutical Industry Information Portal

HomeTagsBig Pharma

All posts by tag

Big Pharma

AI and big data will continue to disrupt pharmaceutical sector

AI and big data have been identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes.

Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility

Catalent’s Anagni site is a world-class biologics and oral dose manufacturing facility that specializes in late-stage and commercial product launches.

AGC Biologics Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities

AGC Biologics announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, currently owned by Novartis Gene Therapies.

Johnson & Johnson agrees to pay $263m to settle NY opioid claims, exits market

Johnson & Johnson has shaken off another lingering liability claim in the US, agreeing a $263 million settlement with New York to resolve lawsuits...

Servier and PRISM BioLab enter drug discovery collaboration for a novel target

Servier, a global independent pharmaceutical Group, and PRISM BioLab, a Japan based biotechnology company with proprietary small molecule drug discovery platform, “PepMetics™Technology”, today announced...

Eisai and BMS Enter Into Strategic Collaboration for MORAb-202 Antibody Drug Conjugate

Bristol Myers Squibb will pay $650 million U.S. dollars to Eisai including $200 million U.S. dollars as payment toward Eisai research and development expenses.

Expert Articles